| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/12/2004 | US20040157780 Epitopes on a number of immunogenic target proteins can be identified using the peptides; antigens include prostate cancer specific antigen (PSA), hepatitis B core and surface antigens (HBVc, HBVs) hepatitis C antigens, Epstein-Barr virus antigens |
| 08/12/2004 | US20040157775 Effector proteins of rapamycin |
| 08/12/2004 | US20040157774 Epitope-tagged recombinant Growth Arrest Specific Gene 6 protein |
| 08/12/2004 | US20040157771 Rank-ligand-induced sodium/proton antiporter polypeptides |
| 08/12/2004 | US20040157344 Multistage sensitive detection |
| 08/12/2004 | US20040157331 Controlling, activating gene operon promoter, induced by aromatic carboxylic acids in bacteria host cell, for industrial scale biosynthesis, expression a heterologous nucleic acid, encoded protein for enzymatic biosynthetic pathway |
| 08/12/2004 | US20040157329 Transfecting chondrocytes and other mesenchymal cells with vectors comprising genes capable of stimulating chondrogenesis, osteogenesis, growth, repair, regeneration and/or restoration of the cellular matrix |
| 08/12/2004 | US20040157327 Pablo, a polypeptide that interacts with BCL-XL, and uses related thereto |
| 08/12/2004 | US20040157314 Inhibitors of Staphylococcus aureus primary sigma factor and uses thereof |
| 08/12/2004 | US20040157313 Ammonia-oxidizing bacteria |
| 08/12/2004 | US20040157312 capable of conferring resistance to different bacteria used in fermentation processes; genetic engineering |
| 08/12/2004 | US20040157310 Methods for enhancing the production of viral vaccines in cell culture |
| 08/12/2004 | US20040157307 for treating a patient with cancer comprising a cancer-specific antigen or a nucleic acid encoding the protein to the patient; genetic engineering; drug delivery; kits |
| 08/12/2004 | US20040157304 Molecular rotary nanomotor and methods of use |
| 08/12/2004 | US20040157300 Glycoprotein vi fusion proteins |
| 08/12/2004 | US20040157298 capable of being crystallized without being complexed to a ligand molecule; human growth hormone receptor (hGHR); for drug design |
| 08/12/2004 | US20040157296 Canine and feline B7-2 proteins, compositions and uses thereof |
| 08/12/2004 | US20040157295 Canine dioxin/aryl hydrocarbon receptor sequences |
| 08/12/2004 | US20040157293 drugs for treating anemia, chronic renal failure, and cancer; genetic engineering |
| 08/12/2004 | US20040157292 Sperm-specific cation channel, CatSper1, and uses therefor |
| 08/12/2004 | US20040157290 Process for preparing serine-rich protein employing cysteine synthase (cysK) gene |
| 08/12/2004 | US20040157289 having an oligonucleotide encoding a small heat shock protein (sHSP) for increasing expression, enhancing folding and increasing solubility; genetic engineering |
| 08/12/2004 | US20040157288 Substances |
| 08/12/2004 | US20040157287 Gene switches; polypeptides and promoter; induce transcription |
| 08/12/2004 | US20040157268 Conformational assays to detect binding to membrane spanning, signal-transducing proteins |
| 08/12/2004 | US20040157261 Kv10.1, a novel voltage-gated potassium channel from human brain |
| 08/12/2004 | US20040157259 Novel human ion channel protein and polynucleotides encoding the same |
| 08/12/2004 | US20040157258 Isolated nucleic acid comprising polynucleotide of given sequence; screening methods for identifying binding partners of polypeptides; use in diagnosis and treatment |
| 08/12/2004 | US20040157250 Contacting a test compound with an expression system comprising an ABCA1 polynucleotide and detecting a change; use in treating coronary artery disease |
| 08/12/2004 | US20040157246 Purified protein encoded by a nucleic acid hybridizable to a DNA of given sequence; use in diagnosis, prognosis and screening for a disposition to cardiovascular disorders |
| 08/12/2004 | US20040157241 Haemophilus adherence and penetration proteins |
| 08/12/2004 | US20040157240 Diagnostic assay and related products |
| 08/12/2004 | US20040157233 metRS2 |
| 08/12/2004 | US20040157232 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 08/12/2004 | US20040157228 by measuring zinc regulated nucleic acid molecules expression level indicative of sub-optimal fermentation in a beer brewing |
| 08/12/2004 | US20040157227 uses detection of relatively increased levels of ghrelin, an exon 3-deleted form of preproghrelin and/or growth hormone secretagogue type 1b receptor expression |
| 08/12/2004 | US20040157225 pharmaceuticals, kits and recombinant animal models for prognosis/prevention |
| 08/12/2004 | US20040157222 for drug screening anti-cancer, asthma, obesity, diabetes, central nervous system and cardiovascular disorder drugs; genetic engineering; kits |
| 08/12/2004 | US20040157221 Novel 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor |
| 08/12/2004 | US20040157216 Polypeptides having a functional domain of interest and methods of identifying and using same |
| 08/12/2004 | US20040156921 inhibiting the growth of endothelial cells and vascularization, including treating rheumatoid, psoriatic and osteoarthritis; screening for a therapeutic agent angiogenesis inhibitors; optionally antiangiogenic, antitumor or immunostimulants |
| 08/12/2004 | US20040156866 Leishmania infantum P36 protein or immunogenic fragment optionally in combination with a compound stimulating the production of a Th1-type cellular immune response |
| 08/12/2004 | US20040156865 M. haemolytica outer membrane protein P1pE as a vaccine or vaccine component against shipping fever |
| 08/12/2004 | US20040156864 Immunogenic HBc chimer particles having enhanced stability |
| 08/12/2004 | US20040156863 administering chimeric, carboxy-terminal truncated hepatitis B virus nucleocapsid (core) protein that is engineered for both enhanced stability of self-assembled particles and the substantial absence of nucleic acid binding by those particles |
| 08/12/2004 | US20040156862 Novel hepatitis C virus peptides and uses thereof |
| 08/12/2004 | US20040156861 elicit native epitope-reactive Cm; may contribute to the development of CTL-epitope based vaccines in viral disease and cancer. |
| 08/12/2004 | US20040156854 Methods for the identification, assessment, and treatment of patients with proteasome inhibition therapy |
| 08/12/2004 | US20040156851 high mobility group box A box that can inhibit release of a proinflammatory cytokine and an agent that inhibits TNF biological activity that is infliximab, etanercept, adalimumab, CDP870, CDP571, Lenercept, or Thalidomide, |
| 08/12/2004 | US20040156848 Therapeutic uses of factors which inhibit or neutralize MIF activity |
| 08/12/2004 | US20040156845 DNA encoding a human histamine receptor of the H3 subtype |
| 08/12/2004 | US20040156842 Uses of human Zven antagonists |
| 08/12/2004 | US20040156841 Human amine transporter |
| 08/12/2004 | US20040156831 The modified holin inactivates the bacterial host prior to production of bacteriophage, so that the bacteriophage infection is non-productive; potential for generation of immune responses against the phage is reduced. |
| 08/12/2004 | US20040156829 Transformed bacteria producing CS6 antigens as vaccines |
| 08/12/2004 | US20040156828 Adeno-associated virus mediated B7.1 vaccination synergizes with angiostatin to eradicate disseminated liver metastatic cancers |
| 08/12/2004 | US20040156824 Vasopermeability enhancing peptide of human interleukin-2 and immunoconjugates thereof |
| 08/12/2004 | US20040156823 inner structures of the syringe are coated with an inductor and the syringe is filled with a body fluid, incubated and a therapeutically-effective protein, e.g., interleukin 1 receptor antagonist, interleukin-4, interleukin-10 and tumour necrosis factor receptor Type I or Type II is formed |
| 08/12/2004 | US20040156822 can be administered alone, or in combination with a colony stimulating factor or hemoregulatory agent |
| 08/12/2004 | US20040156820 Adjuvant combination formulations |
| 08/12/2004 | DE4120345C5 Proteinfragmente aus dem mittleren Bereich des Flagellins von Borrelia burgdorferi, geeignet als Antigene zum spezifischen Antikörpernachweis sowie Verfahren zu ihrer Herstellung Protein fragments from the central region of the flagellin of Borrelia burgdorferi useful as antigens for the specific detection of antibodies as well as methods for their preparation |
| 08/12/2004 | DE10352668A1 Verfahren zur Herstellung von L-Aminosäuren unter Verwendung von Methylotrophen A process for the preparation of L-amino acids using methylotrophs |
| 08/12/2004 | DE10311106A1 Peptide gegen Kälteunverträglichkeit hervorrufende Autoantikörper und ihre Verwendung Peptides against cold intolerance inducing autoantibodies and their use |
| 08/12/2004 | DE10303697A1 Using the third extracellular loop of the MC4 receptor in screening for pharmaceutical agents, e.g. for diagnosis, prevention or treatment of obesity, also new mutated MC4 receptors and their complexes |
| 08/12/2004 | CA2514648A1 Process and device for preparing phycoerythrin with high od ratio |
| 08/12/2004 | CA2514646A1 Factor viii polypeptide |
| 08/12/2004 | CA2514582A1 Amyloid-.beta.(1-42) oligomers, derivatives thereof, antibodies for the same, method for production and use thereof |
| 08/12/2004 | CA2514580A1 Compositions and methods of tolerizing a primate to an antigen |
| 08/12/2004 | CA2514474A1 Freeze-dried fibrin matrices and methods for preparation thereof |
| 08/12/2004 | CA2514419A1 Prostate cancer diagnosis and treatment |
| 08/12/2004 | CA2514328A1 Injectable vaccines against multiple meningococcal serogroups |
| 08/12/2004 | CA2514229A1 Human protooncogene and protein encoded therein |
| 08/12/2004 | CA2514179A1 Modified trafficking patterns for arrestin and g-protein-coupled receptors via arrestin-ubiquitin chimera |
| 08/12/2004 | CA2514062A1 Compositions and methods for treating cancer using igsf9 and liv-1 |
| 08/12/2004 | CA2514058A1 Nucleic acids and corresponding proteins entitled 254p1d6b useful in treatment and detection of cancer |
| 08/12/2004 | CA2514041A1 Mixing and matching tc proteins for pest control |
| 08/12/2004 | CA2514001A1 Autologous or homologous coagulant produced from anticoagulated whole blood |
| 08/12/2004 | CA2513598A1 Use of the cathelicidin ll-37 and derivatives thereof for wound healing |
| 08/12/2004 | CA2513157A1 Peroxisome proliferator-activated receptor |
| 08/12/2004 | CA2512808A1 Regulation of allergen induced gene |
| 08/12/2004 | CA2512169A1 Polymerized hemoglobin solutions having reduced amount of tetramer and method for preparing |
| 08/12/2004 | CA2510482A1 Recombinant hepatitis a virus antigens obtained in plant cells |
| 08/12/2004 | CA2508340A1 Transcriptional activator |
| 08/12/2004 | CA2485568A1 Variant integrin polypeptides and uses thereof |
| 08/12/2004 | CA2453809A1 Amino acid loaded trityl alcohol resins, method of production of amino acid loaded trityl alcohol resins, and biologically active substances and therapeutics produced therewith |
| 08/11/2004 | EP1445319A1 Gene of enzyme reactivating dna damaged by ultraviolet light using visible light |
| 08/11/2004 | EP1445316A1 Novel secreted protein |
| 08/11/2004 | EP1445315A1 Human and mammalian stem cell-derived neuronal survival polypeptides |
| 08/11/2004 | EP1445314A1 Novel glutamic acid receptor and utilization thereof |
| 08/11/2004 | EP1445311A1 Method of amplyfying hematopoietic stem cells |
| 08/11/2004 | EP1444995A1 FGF-2 derived proteins for the preparation of biomaterials or medical devices such as stents |
| 08/11/2004 | EP1444986A1 Pharmaceutical preparation for the improved treatment of blood-clotting disorders |
| 08/11/2004 | EP1444985A2 Use of follistatin for the manufacture of a medicament for the treatment of a non-degenerative nervous system disorder |
| 08/11/2004 | EP1444890A1 RS1 deficient transgenic animal and uses thereof |
| 08/11/2004 | EP1444889A1 Transgenic animal |
| 08/11/2004 | EP1444523A2 Screening for hepatitis c virus entry inhibitors |
| 08/11/2004 | EP1444356A2 Identifying and reducing the allergenicity of food proteins |
| 08/11/2004 | EP1444350A2 Hiv-1 subtype isolate regulatory/accessory genes, and modifications and derivatives thereof |
| 08/11/2004 | EP1444349A2 Process for the preparation of ramipril |
| 08/11/2004 | EP1444341A2 Rankl mimics and uses thereof |